You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

DrugPatentWatch Database Updates: New Patent Additions

✉ Email this page to a colleague

« Back to Dashboard

DrugPatentWatch Database Updates: New Patent Additions

These are patents which have been reported by the FDA since the last major update; they are not yet in the main database.

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Number	Approval Date	Type	RLD	Patent No.	Product	Substance	Delist Requested	Patent Expiration	Date Submitted	Usecode	Patented / Exclusive Use
Esperion Theraps Inc	NEXLIZET	bempedoic acid; ezetimibe	TABLET	211617	001	Feb 26, 2020	RX	Yes	⤷ Try a Trial				⤷ Try a Trial	2021-10-14	U-3224	A METHOD OF TREATING HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA OR ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE BY DECREASING THE LEVEL OF LDL-C USING A FIXED DOSE COMBINATION OF 180 MG BEMPEDOIC ACID AND 10 MG EZETIMIBE
Esperion Theraps Inc	NEXLIZET	bempedoic acid; ezetimibe	TABLET	211617	001	Feb 26, 2020	RX	Yes	⤷ Try a Trial				⤷ Try a Trial	2021-10-14	U-3884	A METHOD OF LOWERING LDL-C OR REDUCING THE RISK OF CARDIOVASCULAR DISEASE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA USING A FIXED-DOSE COMBINATION OF 180 MG BEMPEDOIC ACID AND 10 MG EZETIMIBE
Esperion Theraps Inc	NEXLIZET	bempedoic acid; ezetimibe	TABLET	211617	001	Feb 26, 2020	RX	Yes	⤷ Try a Trial				⤷ Try a Trial	2023-10-03	U-3692	A METHOD OF TREATING HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA OR ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE BY DECREASING THE LEVEL OF LDL-C USING 180 MG BEMPEDOIC ACID AND 10 MG EZETIMIBE
Esperion Theraps Inc	NEXLIZET	bempedoic acid; ezetimibe	TABLET	211617	001	Feb 26, 2020	RX	Yes	⤷ Try a Trial				⤷ Try a Trial	2023-10-03	U-3883	A METHOD OF LOWERING LDL-C OR REDUCING THE RISK OF CARDIOVASCULAR DISEASE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA USING 180 MG BEMPEDOIC ACID AND 10 MG EZETIMIBE
Blueprint Medicines	AYVAKIT	avapritinib	TABLET	212608	004	Jun 16, 2021	RX	Yes	⤷ Try a Trial	Y	Y		⤷ Try a Trial	2024-04-23
Blueprint Medicines	AYVAKIT	avapritinib	TABLET	212608	005	Jun 16, 2021	RX	Yes	⤷ Try a Trial	Y	Y		⤷ Try a Trial	2024-04-23
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Number	>Approval Date	>Type	>RLD	>Patent No.	>Product	>Substance	>Delist Requested	>Patent Expiration	>Date Submitted	>Usecode	>Patented / Exclusive Use

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.